|
|
Volumn 328, Issue 5975, 2010, Pages 137-
|
|
Cancer therapy reform
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMATINIB;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
TRASTUZUMAB;
CANCER CELL;
CANCER COMBINATION CHEMOTHERAPY;
CANCER THERAPY;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MECHANISM;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE POLICY;
HUMAN;
LUNG NON SMALL CELL CANCER;
NONHUMAN;
PANCREAS CANCER;
PATIENT SAFETY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SIGNAL TRANSDUCTION;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DRUG APPROVAL;
GUIDELINES AS TOPIC;
HUMANS;
NEOPLASMS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 77950831001
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1189749 Document Type: Editorial |
|
Times cited : (29)
|
|
References (0)
|
